CARsgen Therapeutics Holdings Limited (02171) submitted a Next Day Disclosure Return dated 06 November 2025. The document indicates a repurchase of 1,734,000 ordinary shares on 06 November 2025 at an average price of HKD 15.17 per share, amounting to 0.3% of the company’s previously issued shares. Following this transaction, the company now holds 576,208,405 shares in issue (excluding treasury shares) and 1,734,000 treasury shares, maintaining a total of 577,942,405 shares.

The announcement also shows that 455,000 shares repurchased in October 2025 await cancellation. According to the repurchase report, the highest and lowest prices per share were HKD 15.8 and HKD 14.35, respectively, for an aggregate paid amount of HKD 26,307,848.5. Under its repurchase mandate, the company is authorized to repurchase up to 57,543,590 shares, with the current total repurchased shares reaching 2,189,000, representing approximately 0.3804% of the issued shares as of the mandate date.